| 
News

India Develops Bird Flu Vaccine

bdbd9205-a6be-4248-ae58-10bf57794c83
A test tube labelled “Bird Flu”.
Photo: REUTERS

India has developed its first indigenous vaccine against the highly pathogenic H5N1 avian influenza virus, commonly known as bird flu, marking a significant breakthrough in efforts to protect the country’s poultry industry from recurring outbreaks.

Union Agriculture Minister Shivraj Singh Chouhan will dedicate the vaccine to the nation on Nov 20 at the Indian Council of Agricultural Research-National Institute of High Security Animal Diseases (ICAR-NIHSAD) in Bhopal, reported NDTV.

Developed after years of research and trials, the inactivated vaccine specifically targets H5N1 Clade 2.3.2.1a, a virus strain circulating in India that causes high mortality among infected chickens.

“This marks a major milestone in safeguarding poultry health, strengthening farm resilience, and advancing Atmanirbharta (self-reliance) in veterinary biologicals,” said ICAR-NIHSAD Director Aniket Sanyal.

The development comes amid fresh bird flu outbreaks in Tamil Nadu and Andhra Pradesh, highlighting the vulnerability of India’s poultry sector.

In Tamil Nadu’s Cuddalore district, 35,647 birds had died as of Nov 13, following an H5N1 outbreak. Around 40,000 chickens were subsequently reported to have been culled as part of containment measures.

Andhra Pradesh also reported outbreaks in Anantapur district in October, prompting authorities to restrict poultry movement.

Between 2006 and 2021, India recorded 341 bird flu outbreaks across 24 states, including 284 attributed to H5N1.

Such outbreaks cause substantial financial losses for poultry farmers, disrupt supply chains and trigger trade restrictions. The 2006 outbreak alone caused estimated direct and indirect losses of between Rs22 billion and Rs30 billion.

The vaccine could provide an additional preventive tool alongside existing measures such as surveillance, testing, culling and farm biosecurity.

H5N1 also poses public health concerns because it can occasionally infect humans exposed to infected birds.

However, the government has yet to announce the vaccine’s commercial availability, deployment strategy or vaccination protocols, which will determine its effectiveness in combating future outbreaks.

promote-epaper-desk
Read this week’s digital edition of Tabla! online
Read our ePaper